PureTech Health Statistics
Want to see GB:PRTC full AI Analyst Report?
PureTech Health (PRTC) Stock Statistics & Valuation Metrics
Total Valuation
PureTech Health has a market cap or net worth of GBX 308.93M. The enterprise value is GBX 183.43M.
- Market Cap
- GBX 308.93M
- Enterprise Value
- GBX 183.43M
Share Statistics
PureTech Health has 245,179,640 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 245,179,640
- Owned by Insiders
- 2.28%
- Owned by Institutions
- 9.15%
Financial Efficiency
PureTech Health’s return on equity (ROE) is -0.36 and return on invested capital (ROIC) is -20.08%.
- Return on Equity (ROE)
- -0.36
- Return on Assets (ROA)
- -0.21
- Return on Invested Capital (ROIC)
- -20.08%
- Return on Capital Employed (ROCE)
- -0.21
- Revenue Per Employee
- 84.94K
- Profits Per Employee
- -2.00M
- Employee Count
- 56
- Asset Turnover
- 0.01
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of PureTech Health is 164.13. PureTech Health’s PEG ratio is -0.24.
- PE Ratio
- 164.13
- PS Ratio
- 63.79
- PB Ratio
- 1.03
- Price to FCF
- -4.94
- Price to Operating Cash Flow
- -4.89
- PEG Ratio
- -0.24
Income Statement
In the last 12 months, PureTech Health had revenue of 4.76M and earned -112.04M in profits. Earnings per share was -0.47.
- Revenue
- 4.76M
- Gross Profit
- 1.34M
- Operating Income
- -100.59M
- Pretax Income
- -113.25M
- Net Income
- -112.04M
- EBITDA
- -97.17M
- Earnings Per Share (EPS)
- -0.47
Cash Flow
In the last 12 months, operating cash flow was -81.43M and capital expenditures -6,032, giving a free cash flow of -81.44M billion.
- Operating Cash Flow
- -81.43M
- Free Cash Flow
- -81.44M
- Free Cash Flow per Share
- -0.34
Dividends & Yields
PureTech Health pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -20.24%
- Earnings Yield
- 0.12%
Stock Price Statistics
- Beta
- 1.37
- 52-Week Price Change
- -1.27%
- 50-Day Moving Average
- 116.72
- 200-Day Moving Average
- 122.84
- Relative Strength Index (RSI)
- 60.28
- Average Volume (3m)
- 665.28K
Important Dates
PureTech Health upcoming earnings date is Apr 29, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 22, 2026
- Next Earnings Date
- Apr 29, 2027
- Ex-Dividend Date
- ―
Financial Position
PureTech Health as a current ratio of 6.59, with Debt / Equity ratio of 6.33%
- Current Ratio
- 6.59
- Quick Ratio
- 6.59
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 2.41
- Interest Coverage Ratio
- -2.15
Taxes
In the past 12 months, PureTech Health has paid -859.66K in taxes.
- Income Tax
- -859.66K
- Effective Tax Rate
- 0.01
Enterprise Valuation
PureTech Health EV to EBITDA ratio is -3.01, with an EV/FCF ratio of -3.66.
- EV to Sales
- 47.22
- EV to EBITDA
- -3.01
- EV to Free Cash Flow
- -3.66
- EV to Operating Cash Flow
- -3.66
Balance Sheet
PureTech Health has GBX 222.51M in cash and marketable securities with GBX 18.57M in debt, giving a net cash position of GBX 203.94M billion.
- Cash & Marketable Securities
- GBX 222.51M
- Total Debt
- GBX 18.57M
- Net Cash
- GBX 203.94M
- Net Cash Per Share
- GBX 0.83
- Tangible Book Value Per Share
- GBX 1.57
Margins
Gross margin is 48.09%, with operating margin of -1618.58%, and net profit margin of 7.53%.
- Gross Margin
- 48.09%
- Operating Margin
- -1618.58%
- Pretax Margin
- 63.25%
- Net Profit Margin
- 7.53%
- EBITDA Margin
- -1566.67%
- EBIT Margin
- -1618.58%
Analyst Forecast
The average price target for PureTech Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -4.11%
- EPS Growth Forecast
- -96.92%
Scores
- Smart Score
- 2
- AI Score
- 51
